Published November 24, 2014 | Version Accepted Version + Supplemental Material
Journal Article Open

Biphenyl-Derived Phosphepines as Chiral Nucleophilic Catalysts: Enantioselective [4+1] Annulations To Form Functionalized Cyclopentenes

  • 1. ROR icon California Institute of Technology
  • 2. ROR icon Massachusetts Institute of Technology

Abstract

Because of the frequent occurrence of cyclopentane subunits in bioactive compounds, the development of efficient catalytic asymmetric methods for their synthesis is an important objective. Introduced herein is a new family of chiral nucleophilic catalysts, biphenyl-derived phosphepines, and we apply them to an enantioselective variant of a useful [4+1] annulation. A range of one-carbon coupling partners can be employed, thereby generating cyclopentenes which bear a fully substituted stereocenter [either all-carbon or heteroatom-substituted (sulfur and phosphorus)]. Stereocenters at the other four positions of the cyclopentane ring can also be introduced with good stereoselectivity. An initial mechanistic study indicates that phosphine addition to the electrophilic four-carbon coupling partner is not the turnover-limiting step of the catalytic cycle.

Additional Information

© 2014 Wiley-VCH Verlag GmbH & Co. Received: June 2, 2014. Revised: July 15, 2014. Article first published online: 6 Oct 2014. Support has been provided by the National Institutes of Health (National Institute of General Medical Sciences: R01-GM57034), EMD Serono (fellowship support for D.T.Z.), the Spanish MICINN (fellowship support for L.R.), Daiichi Sankyo Co., Ltd (fellowship support for T.I.), and Dainippon Sumitomo Pharma Co., Ltd. (fellowship support for Y.F.). We thank Trixia Buscagan, Dr. Søren Kramer, Dr. Allen Oliver (University of Notre Dame), Dr. Nathan D. Schley, Dr. Michael K. Takase, Dr. David VanderVelde, Dr. Scott C. Virgil, and Dr. Ashraf Wilsily for assistance and for helpful discussions.

Attached Files

Accepted Version - nihms687855.pdf

Supplemental Material - anie_201405854_sm_miscellaneous_information.pdf

Files

anie_201405854_sm_miscellaneous_information.pdf

Files (13.5 MB)

Name Size
md5:a2a984a5fd2a6a78c2cab507a06be96f
13.0 MB Preview Download
md5:62aba8fc343ab108207e3ee237d4a28d
506.5 kB Preview Download

Additional details

Identifiers

PMCID
PMC4433032
Eprint ID
50426
Resolver ID
CaltechAUTHORS:20141015-153508295

Funding

NIH
R01-GM57034
EMD Serono
MICINN Ministerio de Ciencia e Innovación (MICINN)
Daiichi Sankyo Co., Ltd.
Dainippon Sumitomo Pharma Co., Ltd.

Dates

Created
2014-10-15
Created from EPrint's datestamp field
Updated
2021-11-10
Created from EPrint's last_modified field